Changing characteristics of epilepsy interventional clinical trials over the last decade: Clinicaltrials.Gov registry.

Introduction: Epilepsy affects about 1% of the world's population (over 50 million). Of these, one-third have refractory or medication-resistant epilepsy. This group of people drives the development and testing of new interventions for epilepsy.